Patents by Inventor Mark R. Alfenito

Mark R. Alfenito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230346913
    Abstract: Recombinant expression of influenza virus surface proteins in the fungus Myceliophthora thermophila strain C1 is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Application
    Filed: July 11, 2023
    Publication date: November 2, 2023
    Applicant: DYADIC INTERNATIONAL INC.
    Inventors: Mark EMALFARB, Teunis Cornelis Verwoerd, Mark R. Alfenito, Mark Baer, Isabelle Legastelois, Marie-Pierre Kazek, Marie-Clotilde Bernard, Jean Dubayle, Richard Kensinger
  • Patent number: 11738080
    Abstract: Recombinant expression of influenza virus surface proteins in the fungus Myceliophthora thermophila strain C1 is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: August 29, 2023
    Assignee: DYADIC INTERNATIONAL INC.
    Inventors: Mark Emalfarb, Teunis Cornelis Verwoerd, Mark R. Alfenito, Mark Baer, Isabelle Legastelois, Marie-Pierre Kazek, Marie-Clotilde Bernard, Jean Dubayle, Richard Kensinger
  • Publication number: 20200215183
    Abstract: Recombinant expression of influenza vims surface proteins in the fungus Myceliophthora thermophila strain Cl is provided. The recombinant proteins are for use in influenza vaccine compositions.
    Type: Application
    Filed: August 9, 2018
    Publication date: July 9, 2020
    Inventors: Mark EMALFARB, Teunis Cornelis VERWOERD, Mark R. ALFENITO, Mark BAER, Isabelle LEGASTELOIS, Marie-Pierre KAZEK, Marie-Clotilde BERNARD, Jean DUBAYLE, Richard KENSINGER
  • Patent number: 9999662
    Abstract: The present invention is directed generally to M1 polypeptides that can be utilized as vaccines and/or antigens for generation of anti-M1 polypeptide antibodies for prophylactic treatment of individuals who are susceptible to infection by influenza virus. The anti-M1 polypeptide antibodies of the invention are useful for treatment of individuals infected with influenza virus, or useful for prophylactic treatment of individuals who are susceptible to infection by influenza virus, or for immune-suppressed individuals who cannot generate an effective antibody response.
    Type: Grant
    Filed: September 21, 2014
    Date of Patent: June 19, 2018
    Assignee: EnGen Bio, Inc.
    Inventors: Mark R. Alfenito, Mark Baer, Doris Bucher
  • Patent number: 6355419
    Abstract: The invention relates to methods for preparing nucleic acid pools useful in hybridization studies. Such methods allow hybridization conditions, such as time, temperature, ionic strength, etc., to be adjusted to increase the likelihood that hybridization to the nucleic acids within each pool is within the linear range of detection (i.e., detectable but not saturating). The methods rely on pooling nucleic acids derived from a sample, based on the degree of representation within the sample, i.e., nucleic acids having similar degrees of representation within in a sample are combined into a pool. The invention also provides arrays and kits produced from pooled nucleic acids, and an improved method for identifying a nucleic acid and/or its representation in a sample.
    Type: Grant
    Filed: April 27, 1998
    Date of Patent: March 12, 2002
    Assignee: Hyseq, Inc.
    Inventor: Mark R. Alfenito
  • Patent number: 4859302
    Abstract: Macromolecules are electroeluted from a matrix by placing the matrix containing the macromolecules of interest in a container, forcing the matrix toward the tip of the container, e.g., by centrifugation, providing an opening at the tip of the container large enough to pass the component, but not the matrix, inserting that container inside another container, placing an electrode in each container together with enough electrophoresis buffer to immerse each electrode, and applying a voltage across the electrodes for a time and under conditions sufficient to cause the macromolecules but not the matrix to migrate from the first container into the second. A kit for performing the electroelution is also described.
    Type: Grant
    Filed: October 22, 1987
    Date of Patent: August 22, 1989
    Assignee: President and Fellows of Harvard College
    Inventor: Mark R. Alfenito